Naxitamab (Mouse IgG1)
Naxitamab (Hu3F8) (Mouse IgG1) is a mouse-derived IgG1 monoclonal antibody targeting the diazoglycoside GD2 (hu3F8) . Naxitamab can be used in the research of neuroblastoma, osteosarcoma, and other GD2-positive cancers[1].
Product Specifications
CAS Number
1879925-92-4
UNSPSC
12352203
Target
Others
Related Pathways
Others
Field of Research
Cancer
Smiles
[Naxitamab(MouseIgG1)]
References & Citations
[1]Cheung NK, et, al. Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo. Oncoimmunology. 2012 Jul 1;1 (4) :477-486.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV632569 1.0 µg DNA
Olr315 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
bsm-52818R-BF488 100 µL
Cardiac Troponin I/TNNC1 Recombinant Antibody, AbBy Fluor™ 488 Conjugated
Sign In for Pricing
View Details